Literature DB >> 18280812

Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes.

Lucio Cocco1, Irene Faenza, Matilde Y Follo, Giulia Ramazzotti, Gian Carlo Gaboardi, Anna Maria Billi, Alberto M Martelli, Lucia Manzoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18280812     DOI： 10.1016/j.advenzreg.2007.11.013

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN： 0065-2571


× No keyword cloud information.
  4 in total

Review 1.  Phosphoinositide-specific phospholipase C in health and disease.

Authors:  Lucio Cocco; Matilde Y Follo; Lucia Manzoli; Pann-Ghill Suh
Journal:  J Lipid Res       Date:  2015-03-27       Impact factor: 5.922

Review 2.  Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders.

Authors:  Stefano Ratti; Matilde Y Follo; Giulia Ramazzotti; Irene Faenza; Roberta Fiume; Pann-Ghill Suh; James A McCubrey; Lucia Manzoli; Lucio Cocco
Journal:  J Lipid Res       Date:  2018-10-04       Impact factor: 5.922

Review 3.  Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy.

Authors:  Philip J Hughes; Ewa Marcinkowska; Elzbieta Gocek; George P Studzinski; Geoffrey Brown
Journal:  Leuk Res       Date:  2009-10-06       Impact factor: 3.156

4.  Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.

Authors:  Matilde Y Follo; Carlo Finelli; Sara Mongiorgi; Cristina Clissa; Costanza Bosi; Nicoletta Testoni; Francesca Chiarini; Giulia Ramazzotti; Michele Baccarani; Alberto M Martelli; Lucia Manzoli; Giovanni Martinelli; Lucio Cocco
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-10       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.